Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci
2012; 16: 43–51.
Mataix-Cols, D van den Heuvel OA. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin North Am
2006; 29: 391–410, .
The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology
2010; 35: 169–191.
Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry
2004; 56: 916–920.
Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry
2007; 61: 1072–1080.
Amygdala activation in response to facial expressions in pediatric obsessive-compulsive disorder. Depress Anxiety
2010; 27: 643–651.
Enhanced brain responsiveness during active emotional face processing in obsessive compulsive disorder. World J Biol Psychiatry
2011; 12: 349–363.
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?
2010; 27: 528–555.
Symptoms of obsessive-compulsive disorder. Am J Psychiatry
1997; 154: 911–917.
A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry
2005; 162: 228–238.
Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord
2005; 88: 99–102.
Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry
1994; 55 (suppl): 18–23.
Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry
2004; 61: 720–730.
van den Heuvel, OA
The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain
2009; 132: 853–868.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
Structured Clinical Interview for DSM-IV Axis I Disorders—Clinician Version (SCID-CV). American Psychiatric Press, 1997.
The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry
2006; 11: 495–504.
Spanish adaptation of the Dimensional Yale-Brown Obsessive-Compulsive Scale. Compr Psychiatry
2010; 51: 641–648.
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry
1989; 46: 1012–1016.
Structured Clinical Interview for DSM-IV-RS Axis 1 Disorders – Non-patient edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, 2007.
Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport
2000; 11: 43–48.
Differential amygdalar response to novel versus newly familiar neutral faces: a functional MRI probe developed for studying inhibited temperament. Biol Psychiatry
2003; 53: 854–862.
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage
2005; 25: 1325–1335.
Conjunction revisited. Neuroimage
2005; 25: 661–667.
REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS One
2011; 6: e25031.
Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry
2013; 73: 321–328.
Atlas of the Human Brain. Academic Press, 2007.
A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
The assessment of anxiety states by rating. Br J Med Psychol
1959; 32: 10.
Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry
2004; 61: 564–576.
Symptom dimensions in OCD: developmental and evolutionary perspectives and Reply to Taylor: combined dimensional and categorical perspectives as an integrative approach to OCD. In Concepts and Controversies in Obsessive-Compulsive Disorder (eds Abramowitz, JS
Houts, AC): 3–21, . Springer Science, 2005.
The distributed human neural system for face perception. Trends Cogn Sci
2000; 4: 223–233.
LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol
2003; 23: 727–738.
There is more than the amygdala: potential threat assessment in the cingulate cortex. Neurosci Biobehav Rev
2011; 35: 1007–1018.
An insular view of anxiety. Biol Psychiatry
2006; 60: 383–387.
Neuroscience. The threatened brain.
2007; 317: 1043–1044.
The relationship between anxiety sensitivity and obsessive-compulsive symptom dimensions. J Behav Ther Exp Psychiatry
2012; 43: 891–896.
Are “obsessive” beliefs specific to OCD?: a comparison across anxiety disorders. Behav Res Ther
2006; 44: 469–480.
Baxter, LR Jr
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry
1988; 145: 1560–1563.
[18F]FDG PET study in obsessive–compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry
1995; 166: 244–250.
Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry
1991; 148: 1240–1242.
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry
1989; 46: 518–523.
A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med
2000; 30: 1037–1050.
Obsessional slowness. Functional studies with positron emission tomography. Brain
1991; 114: 2191–2202.
Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci
2001; 4: 437–441.
Fear processing and social networking in the absence of a functional amygdala. Biol Psychiatry
2012; 72: 70–77.
The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology
2005; 30: 1724–1734.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn) (DSM-5). APA, 2013.